4 patents
Utility
High-transducing HSV vectors
12 Sep 23
Disclosed herein are high transducing replication defective herpes simplex virus (HSV) vectors of McKrae strain.
David M. Krisky, James B. Wechuck, James R. Goss
Filed: 24 Mar 17
Utility
HSV vectors for delivery of NT3 and treatment of CIPN
12 Oct 20
Disclosed herein are compositions and methods for treating neuropathy, embodiments, HSV vectors are provided comprising nucleic acid molecules encoding neurotrophins, such as neurotrophin 3 (NT3).
David M. Krisky, James B. Wechuck, James R. Goss
Filed: 23 Mar 17
Utility
1072bnsfy5s3gcgc739nxw3y r7kdz9w6
1 Jul 20
Disclosed herein are compositions and methods for treating neuropathy, embodiments, HSV vectors are provided comprising nucleic acid molecules encoding neurotrophins, such as neurotrophin 3 (NT3).
David M. Krisky, James B. Wechuck, James R. Goss
Filed: 23 Mar 17
Utility
5xbwimcs7aanpla7olamo3mmo8xmblrbucemtw2yv
24 Jun 20
Disclosed herein are high transducing replication defective herpes simplex virus (HSV) vectors of McKrae strain.
David M. Krisky, James B. Wechuck, James R. Goss
Filed: 23 Mar 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first